The maths nerd who struck vaccine gold
Apr 16, 2021
2 minutes
When Stéphane Bancel left his job at a French medical diagnostics firm to join Moderna in 2011, he told his wife he thought the new job had only a “5% chance” of working out, says The Sunday Times. Moderna then was a heavily loss-making fledgling start-up, majoring on an experimental and unproven technology – messenger RNA. Yet a
You’re reading a preview, subscribe to read more.
Start your free 30 days